SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?

To: Cheeseburger who wrote (701)6/16/1999 3:27:00 PM
From: Laurens  Read Replies (1) | Respond to of 900
 
Nice to see recent recommendations are taking seriously by new investors.
Solid gain moving the stock into the 17's today.
Good volume too.



To: Cheeseburger who wrote (701)6/30/1999 5:57:00 AM
From: cloudy1  Read Replies (1) | Respond to of 900
 
Spoke to physician friend yesterday.His diabetic mother was dying from
fungal infection of kidneys.Choice was between conventional amphotericin and liposomal amphotericin.Liposomal amphotericin was
choice.It avoided 6 weeks of hospitalization and multiple infusions.
I believe she'll have three infusions instead of several per week for
six weeks. She is already much better after one week of Rx.
Point: Liposomal amphotericin was drug of choice.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News